Improve Medical Instruments Co

Improve Medical Instruments Co Liabilities

The The Liabilities of Improve Medical Instruments Co (300030.SZ) as of Nov 18, 2026 is 371.82 M CNY. In the previous year, The Liabilities was 600.28 M CNY — a change of -38.06% (lower).

Liabilities

371.82 MCNY

YoY

-38.06%

Last updated:

In 2025, Improve Medical Instruments Co's total liabilities amounted to 371.82 M CNY, a -38.06% difference from the 600.28 M CNY total liabilities in the previous year.

The Improve Medical Instruments Co Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
695.67 M CNY
Jan 1, 2019
668.54 M CNY
Jan 1, 2020
741.94 M CNY
Jan 1, 2021
794.63 M CNY
Jan 1, 2022
737.57 M CNY
Jan 1, 2023
663.63 M CNY
Jan 1, 2024
600.28 M CNY
Jan 1, 2025
371.82 M CNY
The Improve Medical Instruments Co Liabilities history
YEARLiabilitiesYoY
371.82 MCNY-38.06%
600.28 MCNY-9.55%
663.63 MCNY-10.03%
737.57 MCNY-7.18%
794.63 MCNY+7.10%
741.94 MCNY+10.98%
668.54 MCNY-3.90%
695.67 MCNY-11.06%
782.15 MCNY+51.67%
515.70 MCNY+1.34%
508.88 MCNY+114.42%
237.33 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Improve Medical Instruments Co Stock analysis

What does Improve Medical Instruments Co do? Improve Medical Instruments Co., Ltd. generates revenue through clinical care services, testing laboratory operations, and financial leasing of medical equipment. The company sells vacuum blood collection systems, liquid biopsy tubes, automatic blood collection tube detachers, thromboelastometers, reagents, hospital intelligent blood collection management systems, and sub-medical record systems (EMR). Its products are exported to Russia, Saudi Arabia, Brazil, and South Korea, with additional offerings including masks, instruments, and reagents. The firm serves healthcare providers and medical facilities globally through these product lines and services. The company's revenue streams include the sale of medical equipment and related products, as well as financial leasing services for medical devices. Products like vacuum blood collection systems and hospital management systems target hospitals and laboratories, while exports to countries such as Russia and Brazil indicate a focus on international markets. The firm's product portfolio spans diagnostic tools, blood collection solutions, and EMR systems, catering to diverse healthcare needs. Improve Medical Instruments Co., Ltd. provides clinical care and testing laboratory services alongside product sales, with a strong emphasis on exporting medical equipment and reagents. The firm's export markets include Russia, Saudi Arabia, Brazil, and South Korea, where its vacuum blood collection systems, thromboelastometers, and EMR systems are in demand. Revenue is derived from both direct product sales and financial leasing of medical equipment to healthcare institutions. Improve Medical Instruments Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Improve Medical Instruments Co's Liabilities

Improve Medical Instruments Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Improve Medical Instruments Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Improve Medical Instruments Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Improve Medical Instruments Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Improve Medical Instruments Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Improve Medical Instruments Co stock

The Liabilities of Improve Medical Instruments Co is 371.82 M CNY in 2025.

The Liabilities of Improve Medical Instruments Co changed from 600.28 M CNY to 371.82 M CNY, representing a -38.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Improve Medical Instruments Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Improve Medical Instruments Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Improve Medical Instruments Co

All Key Metrics — Improve Medical Instruments Co